Skip to main content
. Author manuscript; available in PMC: 2019 Nov 20.
Published in final edited form as: Prostate. 2016 Jan 6;76(6):534–542. doi: 10.1002/pros.23135

Fig. 3.

Fig. 3.

AR inhibition sensitizes LNCaP cells to radiation. Graphic representation of clonogenic cell survival assay of LNCaP cells exposed to 0, 2, 4, 6 Gy with or without enzalutamide treatment. *P < 0.05.